Sunday, December 22

Tag: Healthcare Provision

AstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion
27Dec By adminNo Comments
World

AstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion

AstraZeneca has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business.The upfront cash portion of the deal is $1.0 billion, a 62.0% premium to Gracell’s last closing price for its American depository shares of $6.19, AstraZeneca said in a statement Tuesday.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
AstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion
26Dec By adminNo Comments
World

AstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion

AstraZeneca has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business.The upfront cash portion of the deal is $1.0 billion, a 62.0% premium to Gracell’s last closing price for its American depository shares of $6.19, AstraZeneca said in a statement Tuesday.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Matthew Perry’s Death Darkens Ketamine’s Startup Glow
17Dec By adminNo Comments
World

Matthew Perry’s Death Darkens Ketamine’s Startup Glow

By Rolfe Winkler and Brianna AbbottDec. 16, 2023 9:00 pm ETMatthew Perry’s death from the effects of ketamine brought new scrutiny to the booming business to prescribe the powerful anesthetic to patients in clinics and online. Perry was receiving ketamine infusions for depression and anxiety before he was found unresponsive in the pool at his Pacific Palisades, Calif., home on Oct. 28. Drowning, coronary artery disease and effects of buprenorphine, a medication used to treat opioid-use disorder, contributed to his accidental death, the autopsy report released on Friday said.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Diet Company Medifast, Once an Ozempic Skeptic, Embraces Weight Loss Drugs With LifeMD Telehealth Deal
13Dec By adminNo Comments
World

Diet Company Medifast, Once an Ozempic Skeptic, Embraces Weight Loss Drugs With LifeMD Telehealth Deal

Medifast, the weight-loss company that uses coaches and low-calorie shakes and bars to help customers slim down, is diving into the Ozempic and Wegovy market.The company is investing $20 million in LifeMD, a telehealth company that provides access to doctors and nurse practitioners who can prescribe the drugs. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Health Care Roundup: Market Talk
28Nov By adminNo Comments
World

Health Care Roundup: Market Talk

Updated Nov. 28, 2023 12:36 pm ETThe latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0835 ET – Oncoclínicas do Brasil Serviços Médicos has room to boost efficiency even in areas where it has been operating for years, say XP Investimentos analysts Rafael Barros and Raphael Elage in a research note after a meeting with key executives. The cancer clinic operator has a central pharmacy attached to one of its clinics in Rio de Janeiro, but it’s still not integrated with other operations in the city, so the company can still cut unitary costs even without negotiations with suppliers, XP says. Oncoclínicas’ superior relationship with doctors and insurance payors is an advantage, and XP sees the company’s stock as...
Read More
Surprise Medical Billing Law Heaps Pressure on Healthcare Providers
28Nov By adminNo Comments
World

Surprise Medical Billing Law Heaps Pressure on Healthcare Providers

Nov. 28, 2023 6:30 am ET|WSJ ProA law designed to protect patients from surprise medical bills is contributing to the financial distress of some medical-service providers, which say lengthy billing disputes and payment delays with insurers are hurting their ability to stay afloat. The No Surprises Act, which took effect last year, aims to protect patients from surprise medical bills from out-of-network healthcare providers when there are disagreements over reimbursements between insurers and providers. Previously, providers often billed patients to make up for the amounts insurers were unwilling to pay. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Health Care Roundup: Market Talk
17Nov By adminNo Comments
World

Health Care Roundup: Market Talk

Updated Nov. 17, 2023 12:29 pm ETThe latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0846 ET – Twist Bioscience is feeling optimistic about the year ahead after orders picked up and revenue exceeded analyst expectations in its F4Q, which ended Sept. 30. The San Francisco-based biotech company is expecting momentum behind its SynBio product group to be bolstered by Express Genes, its new gene synthesis service, and for its next-generation sequencing business to grow as customers advance their development and commercial plans, CEO Emily Leproust says. Twist is guiding for annual revenue to rise 16% to 18%, with that same growth rate for its SynBio unit. Twist expects 19% to 20% revenue growth for its next-ge...
Read More
Ramsay Sime Darby Health Shortlists Bidders for Over $1.0 Billion Deal
2Nov By adminNo Comments
World

Ramsay Sime Darby Health Shortlists Bidders for Over $1.0 Billion Deal

Updated Nov. 1, 2023 10:41 pm ETTPG-backed hospital operator Columbia Asia and a consortium led by Affinity Partners have emerged as the two shortlisted bidders for buying Asia-focused private hospital group Ramsay Sime Darby Health Care, people familiar with the deal said.One of the people said the 50:50 joint venture between Australian hospital operator Ramsay Health Care and Malaysian conglomerate Sime Darby aims to wrap up its over $1 billion sale by December.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More